Item
Citicoline Sodium (P1554-00)
100% Citicoline Sodium
Food Ingredient
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Non-GMO
Locations
Location name | Address |
---|---|
H&M USA INC. | 80 Gordon Drive Syosset, NY 11791 |
H&M USA Inc. - Bajaj Healthcare Ltd. | Plot No. 1717/18, GIDC, Panoli Taluka Ankleshwar District Bharuch, GJ 394116 IND |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
No Animal Ingredient Statement | H&M USA INC. | 13. Vegetarian_Vegan Statement_Citicoline Sodium_Bajaj.pdf | 4/11/2025 | 4/11/2026 |
BSE - TSE | H&M USA INC. | 3. BSE-TSE Statement_Citicoline Sodium_Bajaj.pdf | 1/31/2024 | 1/30/2027 |
Product Specification Sheet | H&M USA INC. | 8. Typical Specification_Citicoline Sodium_ Bajaj.pdf | 1/31/2024 | 1/30/2027 |
Allergens | H&M USA INC. | Allergens.pdf | 3/23/2025 | 3/23/2027 |
Country of Origin | H&M USA INC. | Country of Origin.pdf | 1/31/2024 | 1/30/2027 |
Halal | H&M USA INC. | Halal Cert_Bajaj_081726.pdf | 10/9/2023 | 8/17/2026 |
Heavy Metal | H&M USA INC. | Heavy Metal Report_CTS-01141019 HM.pdf | 3/23/2025 | 3/23/2027 |
Organic | H&M USA INC. | NotApplicable_Organic.pdf | 3/20/2025 | 3/20/2027 |
Animal Testing Statement | H&M USA INC. | P1554-00 - Animal Testing.pdf | 3/14/2025 | 3/14/2027 |
Animal Testing Statement | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Animal Testing.pdf | 3/14/2025 | 3/14/2027 |
Bioengineered Disclosure Statement | H&M USA INC. | P1554-00 - Bioengineered Disclosure.pdf | 3/14/2025 | 3/13/2028 |
Bioengineered Disclosure Statement | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Bioengineered Disclosure.pdf | 3/14/2025 | 3/13/2028 |
Ingredient Statement | H&M USA INC. | P1554-00 - Composition.pdf | 3/23/2025 | 3/22/2028 |
EtO Statement | H&M USA INC. | P1554-00 - EtO.pdf | 3/14/2025 | 3/14/2027 |
EtO Statement | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - EtO.pdf | 3/14/2025 | 3/14/2027 |
HACCP Process Flow Diagram | H&M USA INC. | P1554-00 - Flow Chart.pdf | 3/14/2025 | 3/14/2027 |
HACCP Process Flow Diagram | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Flow Chart.pdf | 3/14/2025 | 3/14/2027 |
Gluten | H&M USA INC. | P1554-00 - Gluten.pdf | 3/14/2025 | 3/14/2027 |
Gluten | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Gluten.pdf | 3/14/2025 | 3/14/2027 |
GMO | H&M USA INC. | P1554-00 - GMO.pdf | 3/23/2025 | 3/23/2027 |
GRAS/NDI/ODI Statement | H&M USA INC. | P1554-00 - GRAS.pdf | 3/14/2025 | 3/13/2028 |
GRAS/NDI/ODI Statement | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - GRAS.pdf | 3/14/2025 | 3/13/2028 |
Irradiation Status Statement | H&M USA INC. | P1554-00 - Irradiation.pdf | 3/14/2025 | 3/14/2027 |
Irradiation Status Statement | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Irradiation.pdf | 3/14/2025 | 3/14/2027 |
Kosher | H&M USA INC. | P1554-00 - Kosher.pdf | 8/30/2024 | 7/31/2025 |
Pesticide | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Pesticides.pdf | 3/14/2025 | 3/14/2027 |
California Prop. 65 | H&M USA INC. | P1554-00 - Prop 65.pdf | 3/14/2025 | 3/14/2027 |
California Prop. 65 | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Prop 65.pdf | 3/14/2025 | 3/14/2027 |
Residual Statement | H&M USA INC. | P1554-00 - Residual Solvents.pdf | 3/14/2025 | 3/14/2026 |
Residual Statement | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Residual Solvents.pdf | 3/14/2025 | 3/14/2026 |
CoA Sample | H&M USA INC. | P1554-00 - Sample CoA.pdf | 3/23/2025 | 3/23/2027 |
Safety Data Sheet (SDS) | H&M USA INC. | P1554-00 - SDS.pdf | 4/11/2025 | 4/10/2028 |
Sewage Statement | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Sewage Sludge.pdf | 3/14/2025 | 3/14/2027 |
Source Statement | H&M USA INC. | P1554-00 - Source.pdf | 3/14/2025 | 3/13/2028 |
Source Statement | H&M USA Inc. - Bajaj Healthcare Ltd. | P1554-00 - Source.pdf | 3/14/2025 | 3/13/2028 |
Pesticide | H&M USA INC. | Pesticides Statement_Citicoline Sodium_Bajaj_Issued 121323.pdf | 4/21/2025 | 4/21/2027 |
Sewage Statement | H&M USA INC. | Sewage Sludge Statement_Citicoline Sodium_Bajaj_Issued 121323.pdf | 4/21/2025 | 4/21/2027 |
Suitability Requirements | H&M USA INC. | Suitability Requirements.pdf | 8/3/2021 | 8/2/2024 |
WADA/NSF/NFL Statement | H&M USA INC. | Wada Statement_Citicoline Sodium_Bajaj.pdf | 4/12/2025 | 4/12/2027 |